Showing results (871-880 of 2,578) with videos related to

Sort By:
Pageof 258
Molecular Oncology|July 19, 2011
Tumor suppressive activity of prolyl isomerase Pin1 in renal cell carcinomaBrian L Teng, Kathryn E Hacker, Shufen Chen, et al.
Molecular Oncology|September 30, 2011
Hormone replacement therapy dependent changes in breast cancer-related gene expression in breast tissue of healthy postmenopausal womenAnieta M Sieuwerts, Giuseppina De Napoli, Anne van Galen, et al.
Molecular Oncology|December 20, 2011
uPA and uPAR shRNA inhibit angiogenesis via enhanced secretion of SVEGFR1 independent of GM-CSF but dependent on TIMP-1 in endothelial and glioblastoma cellsHari Raghu, Arun Kumar Nalla, Christopher S Gondi, et al.
Molecular Oncology|December 20, 2011
Systems pathology: a critical reviewJose Costa
Molecular Oncology|March 6, 2012
Indirubin derivatives induce apoptosis of chronic myelogenous leukemia cells involving inhibition of Stat5 signalingSangkil Nam, Anna Scuto, Fan Yang, et al.
Molecular Oncology|April 8, 2011
Activation of a pro-survival pathway IL-6/JAK2/STAT3 contributes to glial fibrillary acidic protein induction during the cholera toxin-induced differentiation of C6 malignant glioma cellsMinfeng Shu, Yuxi Zhou, Wenbo Zhu, et al.
Molecular Oncology|August 20, 2011
p53: guardian of ploidyYael Aylon, Moshe Oren
Molecular Oncology|April 16, 2014
Targeted pancreatic cancer therapy with the small molecule drug conjugate SW IV-134Yassar M Hashim, Dirk Spitzer, Suwanna Vangveravong, et al.
Molecular Oncology|May 3, 2014
RalA signaling pathway as a therapeutic target in hepatocellular carcinoma (HCC)Mohamad Ezzeldin, Emma Borrego-Diaz, Mohammad Taha, et al.
Molecular Oncology|April 8, 2014
Dub3 controls DNA damage signalling by direct deubiquitination of H2AXM Rocío Delgado-Díaz, Yusé Martín, Anna Berg, et al.
Pageof 258